Breast Medical Oncologists' Use of Standard Prognostic Factors to Predict a 21-Gene Recurrence Score

BACKGROUND. Half of all breast cancers are early stage, lymph node negative, and hormone receptor positive. A 21-gene (Oncotype DX®; Genomic Health, Inc., Redwood City, CA) recurrence score (RS) is prognostic for recurrence and predictive of chemotherapy benefit. We explored the ability of oncologis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kamal, Arif H., Loprinzi, Charles L., Reynolds, Carol, Dueck, Amylou C., Geiger, Xochiquetzal J., Ingle, James N., Carlson, Robert W., Hobday, Timothy J., Winer, Eric P., Goetz, Matthew P.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2011
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228065/
https://ncbi.nlm.nih.gov/pubmed/21934103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0048
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados